Prevalence and mechanisms of β-lactam resistance in Haemophilus haemolyticus

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 5, 2013, Pages 1049-1053

  Witherden, Elizabeth A ^a   Tristram, Stephen G ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

BLNAR; FtsI gene; Haemophilus influenzae; PBP3

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BINDING PROTEIN; NITROCEFIN; PENICILLIN BINDING PROTEIN 3; PENICILLIN DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE MUTATION; GENETIC MARKER; GENETIC RESISTANCE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HAEMOPHILUS; HAEMOPHILUS HEMOLYTICUS; MINIMUM INHIBITORY CONCENTRATION; NASOPHARYNGEAL ASPIRATION; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PROMOTER REGION; REPLICON; SUBSTITUTION REACTION; THROAT CULTURE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; CHILD, PRESCHOOL; DNA, BACTERIAL; FEMALE; HAEMOPHILUS; HAEMOPHILUS INFECTIONS; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREVALENCE; YOUNG ADULT;

EID: 84877150124     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks532     Document Type: Article

References (22)

1. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 2007; 20: 368-89.
2. Murphy TF, Brauer AL, Sethi S et al. Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae. J Infect Dis 2007; 195: 81-9.
3. Anderson R, Wang X, Briere EC et al. Haemophilus haemolyticus isolates causing clinical disease. J Clin Microbiol 2012; 50: 2462-5.
4. Norskov-Lauritsen N. Detection of cryptic genospecies misidentified as Haemophilus influenzae in routine clinical samples by assessment of marker genes fucK, hap, and sodC. J Clin Microbiol 2009; 47: 2590-2.
5. Wang X, Mair R, Hatcher C et al. Detection of bacterial pathogens in Mongolia meningitis surveillance with a new real-time PCR assay to detect Haemophilus influenzae. Int J Med Microbiol 2011; 301: 303-9.
6. Theodore MJ, Anderson RD, Wang X et al. Evaluation of new biomarker genes for differentiating Haemophilus influenzae from Haemophilus haemolyticus. J Clin Microbiol 2012; 50: 1422-4.
7. Binks MJ, Temple B, Kirkham LA et al. Molecular surveillance of true nontypeable Haemophilus influenzae: an evaluation of PCR screening assays. PLoS One 2012; 7: e34083.
8. Fung WW, O'Dwyer CA, Sinha S et al. Presence of copper- and zinc-containing superoxide dismutase in commensal Haemophilus haemolyticus isolates can be used as a marker to discriminate them from nontypeable H. influenzae isolates. J Clin Microbiol 2006; 44: 4222-6.
9. Norskov-Lauritsen N, Overballe MD, Kilian M. Delineation of the species Haemophilus influenzae by phenotype, multilocus sequence phylogeny, and detection of marker genes. J Bacteriol 2009; 191: 822-31.
10. Ubukata K, Shibasaki Y, Yamamoto K et al. Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 2001; 45: 1693-9.
11. Tristram SG, Franks LR, Harvey GL. Sequences of small blaTEMencoding plasmids in Haemophilus influenzae and description of variants falsely negative for blaTEM by PCR. J Antimicrob Chemother 2012; 67: 2621-5.
12. Osaki Y, Sanbongi Y, Ishikawa M et al. Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae β-lactam resistance by using site-directed mutagenesis and gene recombinants. Antimicrob Agents Chemother 2005; 49: 2834-9.
13. Wiertsema SP, Kirkham LA, Corscadden KJ et al. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule. Vaccine 2011; 29: 5163-70.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
15. Hasegawa K, Yamamoto K, Chiba N et al. Diversity of ampicillinresistance genes in Haemophilus influenzae in Japan and the United States. Microb Drug Resist 2003; 9: 39-46.
16. Takahata S, Ida T, Senju N et al. Horizontal gene transfer of ftsI, encoding penicillin-binding protein 3, in Haemophilus influenzae. Antimicrob Agents Chemother 2007; 51: 1589-95.
17. Shuel ML, Karlowsky KE, Law DK et al. Nonencapsulated or nontypeable Haemophilus influenzae are more likely than their encapsulated or serotypeable counterparts to have mutations in their fucose operon. Can J Microbiol 2011; 57: 982-6.
18. Hasegawa K, Chiba N, Kobayashi R et al. Rapidly increasing prevalence of β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob Agents Chemother 2004; 48: 1509-14.
19. Skaare D, Allum AG, Anthonisen IL et al. Mutant ftsI genes in the emergence of penicillin-binding protein-mediated β-lactam resistance in Haemophilus influenzae in Norway. Clin Microbiol Infect 2010; 16: 1117-24.
20. Hasegawa K, Kobayashi R, Takada E et al. High prevalence of type b β-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. J Antimicrob Chemother 2006; 57: 1077-82.
21. Witherden EA, Kunde D, Tristram SG. An evaluation of SNP-based PCR methods for the detection of β-lactamase-negative ampicillin-resistant Haemophilus influenzae. J Infect Chemother 2012; 18: 451-5.
22. Dabernat H, Delmas C, Seguy M et al. Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 2002; 46: 2208-18.